Summary:
A Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe Endometriosis-Associated Pain.
Qualified Participants Must:
• Have a clinical Diagnosis of endometriosis established by means of documented surgical visualization (laparoscopy or laparotomy) performed within 7 years of entry into the washout period or screening period.
Qualified Participants May Receive:
Stipend for their time and transportation assistance